Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas

Mohammed Soutto1, Dunfa Peng, Mohammad Razvi

  • 1Department of Surgery, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37323, USA.

Cancer
|June 22, 2010
PubMed
Abstract

Insights

Checkpoint with forkhead-associated domain and RING-finger domain (CHFR) expression is silenced in esophageal adenocarcinomas by both epigenetic DNA hypermethylation and genetic DNA copy number loss.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The checkpoint with forkhead-associated domain and RING-finger domain (CHFR) is a crucial mitotic checkpoint protein with demonstrated tumor-suppressor functions.
  • Dysregulation of CHFR is implicated in various cancers, highlighting its importance in maintaining genomic stability.

Purpose of the Study:

  • To investigate the epigenetic and genetic mechanisms responsible for regulating CHFR expression in esophageal adenocarcinomas (EACs).
  • To determine the frequency and interplay of DNA hypermethylation and copy number alterations in CHFR silencing in EACs.

Main Methods:

  • Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC) were used to assess CHFR transcript and protein levels.
  • Quantitative bisulfite pyrosequencing was employed to analyze CHFR promoter DNA methylation.
  • DNA copy number analysis was performed to evaluate genetic alterations of the CHFR locus.

Main Results:

  • CHFR transcript was downregulated in 79% of EACs, with absent or weak protein expression in 75%.
  • Significant CHFR promoter DNA hypermethylation was detected in 31% of EACs, and its reduction with 5-Aza-deoxycytidine restored CHFR mRNA expression.
  • Loss or decrease of CHFR DNA copy number was observed in 59% of EACs, with nine tumors showing copy number loss in the absence of promoter hypermethylation.

Conclusions:

  • Both epigenetic silencing via promoter DNA hypermethylation and genetic mechanisms involving DNA copy number loss contribute to the downregulation of CHFR expression in esophageal adenocarcinomas.
  • These findings elucidate the multifaceted regulation of CHFR in EAC development and progression.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying DNA...
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Chromatin Position Affects Gene Expression02:35

Chromatin Position Affects Gene Expression

Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the timing and level of...